The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 3, 2007, Pages 440-444

  Fukai, Ryuta ^a   Sakao, Yukinori ^a   Sakuraba, Motoki ^a   Oh, Shiaki ^a   Shiomi, Kazu ^a   Sonobe, Satoshi ^a   Saitoh, Yuichi ^a   Miyamoto, Hideaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoembryonic antigen; Lung cancer; N1; Stage II

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; MALE; MULTIVARIATE ANALYSIS; PLEURA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SEX DIFFERENCE; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PULMONARY SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547670338     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.06.011     Document Type: Article

References (24)

1. Martini N., Flehinger B.J., Nagasaki F., and Hart B. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 86 (1983) 646-653
2. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., and Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 107 (1994) 1398-1402
3. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., and Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg 67 (1999) 1572-1576
4. Marra A., Hillejan L., Zaboura G., Fujimoto T., Greschuchna D., and Stamatis G. Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis. J Thorac Cardiovasc Surg 125 (2003) 543-553
5. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2004) 151-157
6. Sayar A., Turna A., Ki{dotless}li{dotless}çgün A., Solak O., Ürer N., and Gürses A. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg 25 (2004) 434-438
7. Martini N., Burt M.E., Bains M.S., McCormach P.M., Rusch V.W., and Ginsberg R.J. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 54 (1992) 460-465
8. van Velzen E., Snijder R.J., Brutel de la Riviere A., Elbers H.J., and van den Bosch J.M. Lymph node type as a prognostic factor for survival in T2N1M0 non-small cell lung carcinoma. Ann Thorac Surg 63 (1997) 1436-1440
9. Tanaka F., Yanagihara K., Otake Y., Yamada T., Shoji T., Miyahara R., Inui K., and Wada H. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer. Eur J Cardiothorac Surg 19 (2001) 555-561
10. Khan O.A., Fitzgerald J.J., Field M.L., Soomro I., Beggs F.D., Morgan W.E., and Duffy J.P. Histological determinants of survival in completely resected T1-2N1M0 non-small cell cancer of the lung. Ann Thorac Surg 77 (2004) 1173-1178
11. Okada M., Nishio W., Sakamoto T., Uchino K., Yuki T., Nagakawa A., and Tsubota N. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78 (2004) 216-221
12. Sakao Y., Sakuragi T., Natsuaki M., and Itoh T. Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung. Ann Thorac Surg 75 (2003) 1113-1117
13. Tomita M., Matsuzaki Y., Shimizu T., Hara M., Ayabe T., and Onitsuka T. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients. Anticancer Res 25 (2005) 3601-3606
14. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 6 (1977) 832-839
15. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
16. Icard P., Regnard J.F., Essomba A., Panebianco V., Magdeleinat P., and Levasseur P. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58 (1994) 811-814
17. Rubins J.B., Dunitz J., Rubins H.B., Maddaus M.A., and Niewoehner D.E. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116 (1998) 412-416
18. Sawabata N., Ohta M., Takeda S., Hirano H., Okumura Y., Asada H., and Maeda H. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 74 (2002) 174-179
19. Muley T., Dienemann H., and Ebert W. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Anticancer Res 23 (2003) 4085-4093
20. Gasper M.J., Diez M., Rodriguez A., Raia T., Martin Duce A., Galvan M., Granell J., and Coca C. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer. Anticancer Res 23 (2003) 3427-3432
21. Alexander J.C., Silverman N.A., and Chretien P.B. Effect of age and cigarette smoking on carcinoembryonic antigen levels. J Am Med Assoc 235 (1976) 1975-1979
22. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311 (1995) 899-909
23. The international Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350 (2004) 351-360
24. Winton T.L., Livingston R., Johnson D., Rigas J., Johnston M., Butts C., Cormier Y., Goss G., Inculet R., Vallieres E., Fry W., Bethune D., Ayoub J., Ding K., Seymour L., Graham B., Tsao M.S., Gandara D., Kesler K., Demmy T., and Shepherd F. Vinorelbin plus cisplatin versus observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597